Literature DB >> 9207038

Effect of in vitro promoter methylation and CGG repeat expansion on FMR-1 expression.

G Sandberg1, M Schalling.   

Abstract

Fragile X syndrome is associated with a CGG repeat expansion in the 5'-untranslated region of the FMR-1 gene. Within the FMR-1 promoter a CpG island is frequently methylated in fragile X patients. To identify the effect of methylation on FMR-1 expression, we transfected methylated and unmethylated constructs containing the FMR-1 promoter in front of the CAT gene (pFXCAT) into COS-1 cells. No difference between methylated and unmethylated DNA was observed initially, whereas reduced CAT mRNA levels were observed 48 h post-transfection of the methylated construct and increased CAT activity from unmethylated DNA was observed at 72 h. To determine the effect of a CGG repeat expansion on gene expression, we inserted >200 CGG repeats between the SV40 promoter and the CAT gene (pSV2CAT). A 3-fold reduction in CAT activity was observed 24-48 h post-transfection. To study the correlation between CGG repeat expansion and FMR-1 transcription, we inserted 200 CGG trinucleotide repeats into the pFXCAT construct. Only a slight difference in mRNA levels was found between cells transfected with pFX(CGG)200CAT or pFXCAT, but a complete lack of CAT activity was observed with introduction of the repeat. We conclude that a moderate size repeat markedly reduces translation. We propose that the presence of a repeat expansion per se is the major factor influencing FMR-1 function in fragile X syndrome.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9207038      PMCID: PMC146834          DOI: 10.1093/nar/25.14.2883

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  31 in total

1.  Lack of correlation between DNA methylation and transcriptional inactivation: the chicken lysozyme gene.

Authors:  S Wölfl; M Schräder; B Wittig
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-01       Impact factor: 11.205

Review 2.  DNA methylation and gene activity.

Authors:  H Cedar
Journal:  Cell       Date:  1988-04-08       Impact factor: 41.582

3.  The KH domain occurs in a diverse set of RNA-binding proteins that include the antiterminator NusA and is probably involved in binding to nucleic acid.

Authors:  T J Gibson; J D Thompson; J Heringa
Journal:  FEBS Lett       Date:  1993-06-21       Impact factor: 4.124

4.  In vitro DNA methylation inhibits FMR-1 promoter.

Authors:  W L Hwu; Y M Lee; S C Lee; T R Wang
Journal:  Biochem Biophys Res Commun       Date:  1993-05-28       Impact factor: 3.575

5.  Tissue specific expression of FMR-1 provides evidence for a functional role in fragile X syndrome.

Authors:  H L Hinds; C T Ashley; J S Sutcliffe; D L Nelson; S T Warren; D E Housman; M Schalling
Journal:  Nat Genet       Date:  1993-01       Impact factor: 38.330

6.  The protein product of the fragile X gene, FMR1, has characteristics of an RNA-binding protein.

Authors:  H Siomi; M C Siomi; R L Nussbaum; G Dreyfuss
Journal:  Cell       Date:  1993-07-30       Impact factor: 41.582

7.  The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation.

Authors:  D Devys; Y Lutz; N Rouyer; J P Bellocq; J L Mandel
Journal:  Nat Genet       Date:  1993-08       Impact factor: 38.330

8.  Human and murine FMR-1: alternative splicing and translational initiation downstream of the CGG-repeat.

Authors:  C T Ashley; J S Sutcliffe; C B Kunst; H A Leiner; E E Eichler; D L Nelson; S T Warren
Journal:  Nat Genet       Date:  1993-07       Impact factor: 38.330

9.  Methylation analysis of CGG sites in the CpG island of the human FMR1 gene.

Authors:  R S Hansen; S M Gartler; C R Scott; S H Chen; C D Laird
Journal:  Hum Mol Genet       Date:  1992-11       Impact factor: 6.150

10.  Physical mapping across the fragile X: hypermethylation and clinical expression of the fragile X syndrome.

Authors:  M V Bell; M C Hirst; Y Nakahori; R N MacKinnon; A Roche; T J Flint; P A Jacobs; N Tommerup; L Tranebjaerg; U Froster-Iskenius
Journal:  Cell       Date:  1991-02-22       Impact factor: 41.582

View more
  10 in total

1.  Cloned human FMR1 trinucleotide repeats exhibit a length- and orientation-dependent instability suggestive of in vivo lagging strand secondary structure.

Authors:  M C Hirst; P J White
Journal:  Nucleic Acids Res       Date:  1998-05-15       Impact factor: 16.971

2.  Increase of FMRP expression, raised levels of FMR1 mRNA, and clonal selection in proliferating cells with unmethylated fragile X repeat expansions: a clue to the sex bias in the transmission of full mutations?

Authors:  U Salat; B Bardoni; D Wöhrle; P Steinbach
Journal:  J Med Genet       Date:  2000-11       Impact factor: 6.318

3.  Epstein-barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma.

Authors:  Gyeong Hoon Kang; Sun Lee; Woo Ho Kim; Hye Won Lee; Jin Cheon Kim; Mun-Gan Rhyu; Jae Y Ro
Journal:  Am J Pathol       Date:  2002-03       Impact factor: 4.307

4.  The role of estrogen receptor-alpha gene TA polymorphism and aromatase gene TTTA polymorphism on peak bone mass attainment in males: is there an additive negative effect of certain allele combinations?

Authors:  Darko Kastelan; Zorana Grubic; Ivana Kraljevic; Ozren Polasek; Tina Dusek; Katarina Stingl; Vesna Kerhin-Brkljacic; Mirko Korsic
Journal:  J Bone Miner Metab       Date:  2009-01-27       Impact factor: 2.626

5.  Promoter-bound trinucleotide repeat mRNA drives epigenetic silencing in fragile X syndrome.

Authors:  Dilek Colak; Nikica Zaninovic; Michael S Cohen; Zev Rosenwaks; Wang-Yong Yang; Jeannine Gerhardt; Matthew D Disney; Samie R Jaffrey
Journal:  Science       Date:  2014-02-28       Impact factor: 47.728

6.  Quantitative analysis of DNA demethylation and transcriptional reactivation of the FMR1 gene in fragile X cells treated with 5-azadeoxycytidine.

Authors:  Roberta Pietrobono; Maria Grazia Pomponi; Elisabetta Tabolacci; Ben Oostra; Pietro Chiurazzi; Giovanni Neri
Journal:  Nucleic Acids Res       Date:  2002-07-15       Impact factor: 16.971

7.  Testing the FMR1 promoter for mosaicism in DNA methylation among CpG sites, strands, and cells in FMR1-expressing males with fragile X syndrome.

Authors:  Reinhard Stöger; Diane P Genereux; Randi J Hagerman; Paul J Hagerman; Flora Tassone; Charles D Laird
Journal:  PLoS One       Date:  2011-08-31       Impact factor: 3.240

8.  Mode and Tempo of Microsatellite Evolution across 300 Million Years of Insect Evolution.

Authors:  Michelle Jonika; Johnathan Lo; Heath Blackmon
Journal:  Genes (Basel)       Date:  2020-08-16       Impact factor: 4.096

9.  Matamatas Chelus spp. (Testudines, Chelidae) have a remarkable evolutionary history of sex chromosomes with a long-term stable XY microchromosome system.

Authors:  Patrik F Viana; Eliana Feldberg; Fábio Hiroshi Takagui; Sabrina Menezes; Richard C Vogt; Tariq Ezaz
Journal:  Sci Rep       Date:  2022-04-23       Impact factor: 4.996

10.  Fragile X (CGG)n repeats induce a transcriptional repression in cis upon a linked promoter: evidence for a chromatin mediated effect.

Authors:  Simon P Chandler; Pushpa Kansagra; Mark C Hirst
Journal:  BMC Mol Biol       Date:  2003-03-21       Impact factor: 2.946

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.